At Elevian, we are developing new medicines that promote recovery and regeneration. Our lead program is a recombinant protein for the treatment of stroke in the days following the event, for which there are currently no viable treatments. By promoting regeneration, Elevian’s medicines have the potential to treat and prevent many aging-associated diseases.
Looking for a particular Elevian, Inc. employee's phone or email?
The Elevian, Inc. annual revenue was $2 million in 2026.
Tom McCracken is the EVP, General Counsel of Elevian, Inc..
5 people are employed at Elevian, Inc..
Elevian, Inc. is based in Newton, Massachusetts.
The NAICS codes for Elevian, Inc. are [5417, 54171, 541713, 541, 54].
The SIC codes for Elevian, Inc. are [873, 87].